Acorn Wealth Advisors »

Zentalis Pharmaceuticals shares owned by Acorn Wealth Advisors

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Acorn Wealth Advisors from 13F filings

Historical chart of Acorn Wealth Advisors investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Acorn Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Acorn Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $30k 20k 1.51
2025-06-30 $23k 20k 1.16

More positions owned by Acorn Wealth Advisors

Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vaneck Etf Trust Mrngstr Wde Moat (MOAT)
Microsoft Corporation (MSFT)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Apple (AAPL)
Select Sector Spdr Tr Technology (XLK)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Index Fds Total Stk Mkt (VTI)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Pgim Etf Tr Pgim Ultra Sh Bd (PULS)
Ishares Tr Msci Usa Min Vol (USMV)
JPMorgan Chase & Co. (JPM)

View all positions for Acorn Wealth Advisors

Top funds holding Zentalis Pharmaceuticals

Matrix Capital Management Company
Vanguard Group
Acadian Asset Management
Renaissance Technologies
Citadel Advisors
Tang Capital Management
Two Sigma Advisers
D. E. Shaw & Co
Two Sigma Investments
Decheng Capital
BlackRock
Balyasny Asset Management
Morgan Stanley
GSA Capital Partners
PRIMECAP Management Company

View all funds holding Zentalis Pharmaceuticals